2023 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting.

Détails

Ressource 1Télécharger: 38458657.pdf (542.68 [Ko])
Etat: Public
Version: Final published version
Licence: CC BY-NC-ND 4.0
ID Serval
serval:BIB_87AB27244127
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
2023 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting.
Périodique
ESMO open
Auteur⸱e⸱s
Herrstedt J., Clark-Snow R., Ruhlmann C.H., Molassiotis A., Olver I., Rapoport B.L., Aapro M., Dennis K., Hesketh P.J., Navari R.M., Schwartzberg L., Affronti M.L., Garcia-Del-Barrio M.A., Chan A., Celio L., Chow R., Fleury M., Gralla R.J., Giusti R., Jahn F., Iihara H., Maranzano E., Radhakrishnan V., Saito M., Sayegh P., Bosnjak S., Zhang L., Lee J., Ostwal V., Smit T., Zilic A., Jordan K., Scotté F.
Collaborateur⸱rice⸱s
participants of the MASCC/ESMO Consensus Conference 2022. Electronic address: clinicalguidelines@esmo.org
ISSN
2059-7029 (Electronic)
ISSN-L
2059-7029
Statut éditorial
Publié
Date de publication
02/2024
Peer-reviewed
Oui
Volume
9
Numéro
2
Pages
102195
Langue
anglais
Notes
Publication types: Practice Guideline
Publication Status: ppublish
Mots-clé
Humans, Vomiting/prevention & control, Vomiting/chemically induced, Nausea/prevention & control, Nausea/chemically induced, Radiation Oncology, MASCC–ESMO Clinical Practice Guideline, chemotherapy, nausea and vomiting, prevention, radiotherapy
Pubmed
Open Access
Oui
Création de la notice
14/03/2024 18:07
Dernière modification de la notice
15/03/2024 8:21
Données d'usage